Corcept Therapeutics
CORT
#2078
Rank
HK$70.62 B
Marketcap
HK$670.29
Share price
1.71%
Change (1 day)
44.97%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2025 (TTM): HK$5.77 Billion

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM ) is HK$5.76 Billion. In 2024 the company made a revenue of HK$5.24 Billion an increase over the revenue in the year 2023 that were of HK$3.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$5.77 B10.24%
2024 HK$5.24 B39.11%
2023 HK$3.76 B19.99%
2022 HK$3.13 B10.02%
2021 HK$2.85 B4.03%
2020 HK$2.74 B14.93%
2019 HK$2.38 B21.32%
2018 HK$1.96 B58.18%
2017 HK$1.24 B97.24%
2016 HK$0.63 B61.8%
2015 HK$0.38 B89.25%
2014 HK$0.20 B156.44%
2013 HK$80.31 M213.31%
2012 HK$25.63 M
2011 N/A
2010 N/A-100%
2009 HK$0.23 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
HK$717.34 B 12,332.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$373.92 B 6,380.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$438.83 B 7,505.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$462.55 B 7,917.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$488.76 B 8,371.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$500.04 B 8,566.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$2.36 B-59.01%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$2.44 B-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$24.08 B 317.45%๐Ÿ‡บ๐Ÿ‡ธ USA